mots-c vs aod9604 is commonly explored for energy utilization, endurance, and metabolic support, while AOD Stop using FAT LOSS 💊

For pharmacies like our Texas caller, this meant immediate cessation of established treatment protocols

Alliance for Pharmacy Compounding

We pull multiple samples per batch and test against the same reference every time

After 15 years of compounding peptides for patientsBPC-157 for inflammatory bowel disease, CJC-1295 for growth hormone deficiencythe FDA had just added his two highest-volume compounds to their Category 2 list

The Category 2 Bombshell In October 2023, the FDA fundamentally altered the peptide landscape by designating 17 peptides as Category 2 substancesbanned from all compounding regardless of prescription validity or patient need

Companies selling research peptides walk a careful line